Insider Trading activities of Flexion Therapeutics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Flexion Therapeutics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Flexion Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Flexion Therapeutics Inc since 2005. The reporting company's ticker symbol is FLXN. The reporting company's CIK number is 1419600.
The total value of stock buying since 2005 is $67,287,061.
The total value of stock sales since 2005 is $5,165,382.
The total value of stock option exercises since 2005 is $262,743.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Flexion Therapeutics Inc (FLXN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 7,700 $184,206 0 $0 0 $0
2017-10 0 $0 0 $0 19,366 $0
2017-09 4,000 $96,950 0 $0 0 $0
2017-08 1,375 $34,925 0 $0 0 $0
2017-06 11,580 $198,088 0 $0 0 $0
2017-05 0 $0 6,830 $130,453 0 $0
2017-04 0 $0 5,000 $142,650 0 $0
2017-03 0 $0 8,000 $171,040 3,000 $23,658
2017-02 0 $0 38,434 $770,759 30,000 $236,580
2017-01 0 $0 5,000 $91,745 0 $0
2016-12 0 $0 10,000 $184,630 0 $0
2016-11 38,332 $690,408 0 $0 0 $0
2016-06 2,169,359 $30,363,443 0 $0 0 $0
2016-05 20,000 $196,055 0 $0 10,369 $1,690
2015-09 1,000 $23,000 0 $0 0 $0
2015-06 0 $0 150,000 $3,091,989 0 $0
2015-03 0 $0 12,000 $292,348 5,000 $815
2015-02 0 $0 4,000 $89,768 0 $0
2014-12 500,000 $8,500,000 0 $0 0 $0
2014-10 0 $0 10,000 $200,000 0 $0
2014-02 2,076,922 $26,999,986 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Flexion Therapeutics Inc insiders (FLXN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-21 Bodick Neil (Chief Scientific Officer) Buy 2,700 24.52 66,206
2017-11-08 Clayman Michael D. (President and CEO) Buy 5,000 23.60 118,000
2017-10-06 Bodick Neil (Chief Scientific Officer) Option Ex 4,566 .00 0
2017-10-06 Clayman Michael D. (President and CEO) Option Ex 14,800 .00 0
2017-09-05 Deniz Yamo (Chief Medical Officer) Buy 1,000 24.20 24,200
2017-09-01 Deniz Yamo (Chief Medical Officer) Buy 3,000 24.25 72,750
2017-08-31 Deniz Yamo (Chief Medical Officer) Buy 1,375 25.40 34,925
2017-06-16 Stejbach Mark (Director) Buy 1,580 17.02 26,888
2017-06-05 Clayman Michael D. (President and CEO) Buy 5,000 17.23 86,150
2017-06-05 Colella Samuel D (Director) Buy 5,000 17.01 85,050
2017-05-15 Bodick Neil (Chief Medical Officer) Sale 6,830 19.10 130,453
2017-04-17 Bodick Neil (Chief Medical Officer) Sale 5,000 28.53 142,650
2017-03-23 Driscoll Frederick W (Chief Financial Officer) Sale 3,000 23.00 69,000
2017-03-23 Driscoll Frederick W (Chief Financial Officer) Option Ex 3,000 7.89 23,658
2017-03-17 Bodick Neil (Chief Medical Officer) Sale 5,000 20.41 102,040
2017-02-28 Driscoll Frederick W (Chief Financial Officer) Sale 33,434 20.19 674,999
2017-02-28 Driscoll Frederick W (Chief Financial Officer) Option Ex 30,000 7.89 236,580
2017-02-24 Bodick Neil (Chief Medical Officer) Sale 5,000 19.15 95,760
2017-01-20 Bodick Neil (Chief Medical Officer) Sale 5,000 18.35 91,745
2016-12-21 Bodick Neil (Chief Medical Officer) Sale 10,000 18.46 184,630
2016-11-23 Clayman Michael D. (President and CEO) Buy 1,667 18.41 30,687
2016-11-22 Clayman Michael D. (President and CEO) Buy 1,666 17.95 29,899
2016-11-21 Clayman Michael D. (President and CEO) Buy 1,666 17.90 29,828
2016-11-21 Colella Samuel D (Director) Buy 33,333 18.00 599,994
2016-06-21 Colella Samuel D (Director) Buy 18,726 13.69 256,265
2016-06-20 Colella Samuel D (Director) Buy 6,778 13.84 93,821
2016-06-14 Merrifield C Ann (Director) Buy 1,000 13.39 13,387
2016-06-08 Praeger Robin L. (10% Owner) Buy 714,285 14.00 9,999,990
2016-06-08 Robertson Rebecca B (10% Owner) Buy 714,285 14.00 9,999,990
2016-06-08 Colella Samuel D (Director) Buy 714,285 14.00 9,999,990
2016-05-23 Clayman Michael D. (President and CEO) Option Ex 10,369 .16 1,690
2016-05-20 Clayman Michael D. (President and CEO) Buy 2,000 10.40 20,810
2016-05-19 Bodick Neil (Chief Medical Officer) Buy 850 10.00 8,500
2016-05-19 Clayman Michael D. (President and CEO) Buy 2,000 9.65 19,298
2016-05-18 Bodick Neil (Chief Medical Officer) Buy 2,100 10.20 21,420
2016-05-18 Clayman Michael D. (President and CEO) Buy 2,000 10.23 20,466
2016-05-17 Bodick Neil (Chief Medical Officer) Buy 800 9.60 7,680
2016-05-17 Clayman Michael D. (President and CEO) Buy 2,000 9.73 19,466
2016-05-17 Driscoll Frederick W (Chief Financial Officer) Buy 2,500 9.87 24,667
2016-05-16 Bodick Neil (Chief Medical Officer) Buy 1,250 9.40 11,750
2016-05-16 Clayman Michael D. (President and CEO) Buy 2,000 9.51 19,026
2016-05-16 Driscoll Frederick W (Chief Financial Officer) Buy 2,500 9.19 22,972
2015-09-11 Merrifield C Ann (Director) Buy 1,000 23.00 23,000
2015-06-22 Novo A/s (10% Owner) Sale 63,412 20.55 1,302,862
2015-06-19 Novo A/s (10% Owner) Sale 50,888 20.07 1,021,220
2015-06-18 Novo A/s (10% Owner) Sale 35,700 21.51 767,907
2015-03-24 Clayman Michael D. (President and CEO) Option Ex 5,000 .16 815
2015-03-16 Bodick Neil (Chief Medical Officer) Sale 4,000 25.38 101,500
2015-03-10 Bodick Neil (Chief Medical Officer) Sale 4,000 24.26 97,056
2015-03-04 Bodick Neil (Chief Medical Officer) Sale 4,000 23.45 93,792
2015-02-26 Bodick Neil (Chief Medical Officer) Sale 4,000 22.44 89,768
2014-12-17 Novo A/s (10% Owner) Buy 500,000 17.00 8,500,000
2014-10-29 Sofinnova Partners Sas Sale 10,000 20.00 200,000
2014-02-18 Tordjman Rafael (Director) Buy 230,769 13.00 2,999,997
2014-02-18 Versant Development Fund Iii, L.p. (10% Owner) Buy 307,692 13.00 3,999,996
2014-02-18 Sofinnova Partners Sas (10% Owner) Buy 230,769 13.00 2,999,997
2014-02-18 Novo A/s (Other) Buy 692,308 13.00 9,000,004
2014-02-18 Bolzon Bradley J Phd (Director) Buy 307,692 13.00 3,999,996
2014-02-18 Colella Samuel D (Director) Buy 307,692 13.00 3,999,996

Insider trading activities including stock purchases, stock sales, and option exercises of FLXN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Flexion Therapeutics Inc (symbol FLXN, CIK number 1419600) see the Securities and Exchange Commission (SEC) website.